Phase 3 Readout~month

Phase 3 Topline: A Phase 3, Multicenter, Randomized, Placebo- and Active Comparator-Controlled Study Evaluating the E

Indication
Psoriasis

Other upcoming events for ENTA

Phase 2 StartPhase 2 Start: Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Z
Phase 1 StartPhase 1 Start: A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Phase 3 ReadoutPhase 3 Topline: A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-
Phase 3 ReadoutPhase 3 Topline: Comparison of Efficacy of Tranexamic Acid Versus Vasopressin in Blood Loss Among Placenta Previa Pat
Phase 3 ReadoutPhase 3 Topline: A Randomized, Open, Multicenter Phase III Clinical Trial of Combination of Sintilimab Injection (IBI

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3, Multicenter, Randomized, Placebo- and Active Comparator-Controlled Study Evaluating the E — ENTA Phase 3 Readout | BioSniper